Dr. Kai Chen

Pradeep Natarajan is a Cardiologist in Boston,, Massachusetts. Dr. Natarajan has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, High Cholesterol, Heart Transplant, and Pacemaker Implantation.

Dr. Paul M. Ridker is director of the Center for Cardiovascular Disease Prevention, a translational research unit at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also the Eugene Braunwald Professor of Medicine at Harvard School of Medicine (HMS).Dr. Ridker received his medical degree from HMS. He then completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Ridker is board certified in internal medicine. He provides outpatient services at the Southern Jamaica Plain Health Center, a public-health clinic affiliated with BWH and HMS. His clinical interests include coronary artery disease and the underlying causes and prevention of atherosclerotic disease.Dr. Ridker is the author of over 500 peer-reviewed publications, 150 reviews and book chapters, and five textbooks related to cardiovascular medicine. Dr. Ridker’s primary research focus has involved inflammatory mediators of heart disease and the molecular and genetic epidemiology of hemostasis and thrombosis, with particular interests in biomarkers for coronary disease, “predictive” medicine, and the underlying causes and prevention of atherosclerotic disease. Between the years 2000 and 2010, he was among the 10 most often cited researchers in cardiovascular medicine worldwide. Dr. Ridker been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Ridker is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Atherosclerosis, Unstable Angina, High Cholesterol, Heart Attack, and Percutaneous Coronary Intervention (PCI).

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as a Distinguished provider by MediFind in the treatment of High Cholesterol. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).